Clinical Trials Directory

Trials / Completed

CompletedNCT07331116

Echocardiography Findings in Patients With Myocardial Fibrosis and Severe Aortic Stenosis

Correlations Between Biopsy Verified Myocardial Fibrosis and Echocardiography Parameters in Patients With Severe Aortic Stenosis

Status
Completed
Phase
Study type
Observational
Enrollment
22 (actual)
Sponsor
Norwegian University of Science and Technology · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Patients with aortic stenosis waiting for aortic valve repair were investigated with echocardiography preoperatively, and a myocardial biospy was taken during the operation. The investigators aim to perform a retrospective analysis of these data, to look for correlations between biopsy-verified myocardial fibrosis and echocardiography parameters. The patients also had cardiac magnetic resonance imaging performed, for a non-invasive quantification of myocardial fibrosis.

Detailed description

The primary purpose of the study is to retrospectively compare echocardiography measurements with a myocardial biopsy taken perioperatively in patients with aortic stenosis requiring aortic valve replacement. Echocardiography and endomyocardial biopsy have been performed in close proximity in time. Due to a small sample size and a large number of echocardiography measurements being possible, only a limited number of prespecified comparisons are performed. Cardiac magnetic resonance (CMR) was also performed in patients without contraindication, providing a non-invasive gold standard for diffuse fibrosis and replacement fibrosis. A secondary goal will be to investigate how echocardiography parameters performs compared to CMR in quantifying myocardial fibrosis.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTTransthoracic echocardiographyTransthoracic echocardiography, performed close in time to the endomyocardial biopsy taken during aortic valve replacement procedure
DIAGNOSTIC_TESTCardiac magnetic resonance imagingCardiac magnetic resonance imaging was taken on selected patients without contraindications. The CMR protocol was changed midway during study inclusions (May 2017), in order to better be able to quantify myocardial fibrosis.

Timeline

Start date
2014-04-10
Primary completion
2021-02-16
Completion
2021-03-01
First posted
2026-01-09
Last updated
2026-04-17

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT07331116. Inclusion in this directory is not an endorsement.